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1 Introduction
Lumbar spine fusion procedures are commonly used to alle-
viate pain and suffering due to degenerative disc disease, 
spinal stenosis, displacement of disc without myelopathy, 
and acquired spondylolisthesis [41]. One of the parameters 
for a successful procedure is the fusion of the bone graft 
volume. The fusion rate is a multi-factorial process depend-
ing on instrumentation (none, rigid, semi-rigid), number of 
levels fused (1, 2, 3 or more), graft location (posterolateral, 
posterior interbody, anterior interbody), and graft source 
(autograft, allograft, synthetic) [5, 42]. Typical rates vary 
considerably depending on these factors and the surgical 
approach from 46 % success rate for a transforaminal inter-
body fusion [23] to 100 % for posterolateral lumbar inter-
body and posterolateral fusions [26, 32, 54]. Obviously, the 
fusion rates for patients with additional risk factors are sig-
nificantly lower [27].
Given the number of patients undergoing lumbar spi-
nal fusion procedures and the percentage of failed fusions, 
consideration of adjunctive therapies to further enhance 
the probability of fusion is warranted. Biophysical thera-
pies utilizing stimulation by electromagnetic fields (EMFs) 
include combined magnetic field (CMF) and electric field 
(EF) devices. Furthermore, the generation of EMFs can be 
classified as direct current, capacitively coupled, and induc-
tively coupled [48]. For patients using EMF devices, fusion 
rates increase an average of 18–32 % over controls [21, 28, 
34, 37]. For example, in a study using a CMF device, Lin-
novitz et al. [34] reported a statistically significant 21 % 
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increase in fusion rates compared with placebo. Criteria for 
inclusion were for primary, noninstrumented, intertrans-
verse fusion of one or two vertebral levels.
Furthermore, the successful repair and consolidation 
of the fusion by an EMF device is directly correlated with 
the coverage of the spinal fusion volume by the stimula-
tory fields. Carter et al. [6] examined the current distribu-
tion of a capacitively coupled electric field device operat-
ing at 60 kHz and determined the magnitude of the input 
current to induce a biological response in a vertebral body. 
The anatomical model encompassed vertebrae from T5 to 
L5 and was derived from five computerized tomographic 
scans of the female abdomen. Another computational study 
investigated the current density generated by a capacitively 
coupled electric field device within a fracture of the spine, 
but did not draw any conclusions regarding the coverage of 
the spine by the EF [3]. Zborowski et al. [55] modelled the 
magnetic flux density (MFD) generated by a pulsed EMF 
device. Maxwell equations were solved using a piecewise 
analytical solution of the magnetic vector potential with an 
emphasis on visualization of the fields. The time derivative 
of the MFD was superimposed a posteriori onto a human 
spine. The underlying assumption of these models was that 
the EF, but not the MFD, was therapeutically relevant.
The CMF device in Linnovitz et al. [34] utilized an 
extremely low-frequency magnetic field (ELF-MF) com-
bined with a static magnetic field to achieve clinical effi-
cacy. The amplitude of the magnetic fields for the device 
was on the order of the earth’s magnetic field. The fre-
quency was chosen to satisfy the ion cyclotron resonance 
theory for Ca++ and Mg++ [33]. Given this low amplitude 
and extremely low frequency, it is difficult to understand 
how the CMF signal could be perceived by a cell because 
of the thermally noisy environment surrounding it [1]. In 
fact, the interaction of Ca++ with an ELF-MF as prescribed 
by ion cyclotron resonance theory occurs at a much larger 
length scale (radius of gyration of the ion) than can be rec-
onciled with distances associated with biochemical reac-
tions [47].
A number of other biophysical theories have been 
advanced to elucidate the transduction of an externally 
applied ELF-MF into a local signal that can be detected at 
the level of an individual cell. Larmor precession [38, 39], 
radical pairs [49], F-actin-based Ca2+ signalling [20], elec-
tron tunnelling within enzymes [4], and Faraday coupling 
are the prevailing theories. In addition, the interaction of 
ions with ELF-MF contained within the coherence domains 
of water has been forwarded as a potential transduction 
mechanism [9, 13]. There is currently no consensus as to 
which theory best explains the coupling of ELF-MF to cel-
lular phenomenon [17].
The transduction of an ELF-MF into a biochemical 
signal was demonstrated in early studies [14–16, 45]. For 
example, CMFs were shown to modulate the time course 
of insulin-like growth factor II (IGF-II) assayed at both 24 
and 72 h post exposure in fracture callus obtained from the 
femurs of Sprague–Dawley rats [45]. More recent studies 
have described positive clinical effects on a diverse range of 
medical conditions and disease states [2, 8, 10, 12, 35, 44, 
52]. However, these results are based on pilot studies and 
require additional clinical trials for substantiation. An ELF-
MF limited osteoporosis due to spinal cord injury as indi-
cated by improvements in bone mineral density and content 
as well as biochemical markers for bone including colla-
gen I, osteocalcin, and alkaline phosphatase [36]. Finally, 
Ledda et al. [31] exposed human mesenchymal stem cells 
to a high-amplitude ELF-MF resulting in changes in cell 
morphology and increases in osteoblastic markers. The bio-
logical effects are likely due to both electric and magnetic 
field effects due to the high rate of change in the magnetic 
field with respect to time.
The purpose of this study was to model the therapeu-
tic field associated with the only CMF device used as an 
adjunctive therapy for spinal fusion, the SpinaLogic® bone 
growth stimulator. The model was first exercised to test the 
hypothesis that CMF provide targeted and complete cov-
erage of lumbar spinal fusion sites for both interbody and 
posterolateral procedures. An additional hypothesis was 
tested to determine the validity of the assumption that the 
therapeutic effect of EMF stimulation for spinal fusions 
can only be attributed to the electric field.
2  Methods
2.1  Device description
The SpinaLogic® bone growth stimulator (DJO, Vista, CA) 
consists of a three-dimensional patient interface contoured 
to follow the curvature of the lumbar spine, a control box 
containing the electronics, and a battery pack (Fig. 1). The 
device is used for 30 consecutive minutes a day until fusion 
occurs as determined by the treating physician. The patient 
interface consists of a single transducer coil to generate the 
magnetic field and a magnetoresistive element to provide 
feedback as to the magnitude of the earth’s magnetic field 
which ranges from 25 to 65 microTesla (μT). The coil is 
constructed using 504 turns of 30-gauge copper magnetic 
wire. Its projection in two dimensions is an ellipse with a 
major axis of 0.24 m and a minor axis of 0.19 m. When 
viewed from the side, the coil forms a circular arc with 
an approximate radius of 0.81 m, and, when viewed from 
the top, the coil forms a circular arc with an approximate 
radius of 0.56 m (Fig. 2). 
When the specified current is applied to the coil, it 
generates an extremely low-frequency and extremely 
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low-intensity magnetic field that has both alternating and 
direct current (AC and DC) components, labelled a com-
bined magnetic field (CMF). Specifically, the field oscil-
lates sinusoidally at a frequency of 76.6 Hertz with an 
AC component of 40.0 ± 8.0 μT, peak to peak, and a DC 
component of 20.0 ± 2.0 μT and is calibrated at a distance 
of 0.10 m normal to the projected plane of the coil (see 
Fig. 2). The tolerances for the AC and DC fields are applied 
to the component of the MFD, Bz, normal to the plane of 
the coil. It is important to note that specifications based on 
these tolerances (AC: 32.0–48.0 μT, DC: 18.0–22.0 μT) 
are not the same as the limits of the therapeutic field, which 
are currently unknown.
Clinical data from Linnovitz et al. [34] were used to 







that was efficacious. First, the soft tissue distance to the 
intervertebral disc space for L1–L2 was calculated based on 
regression equations derived from renal scintigraphy (the 
kidneys are located adjacent to the disc space) [46]. Since 
most of the spinal fusions in the study were located at the 
L4–L5 disc level, an adjustment was made to account for 
the additional depth from L1–L2 to the L4–L5 disc space 
based on the anatomical CAD model. The depth was also 
augmented to account for the cross section of the coil and 
packaging for the device. Finally, the MFD for the trapezoi-
dal coil tested in the clinical trial was modelled using the 
Biot–Savart law [43]. The magnitude of the MFD to L4–L5 







∣ of 22.0 μT. No upper limit was assumed for 
the MFD. Thus, the specification for a therapeutic magnetic 
field was any value of the MFD above the lower limit.
2.2  Anatomical spine model
An anatomically based CAD model of the lumbar spine of 
a 50th percentile female was adapted for use in the simu-
lations (BodyWorks, NZ, http://www.zetec.co.nz/body-
works/). A female lumbar spine model was used because 
Fig. 1  SpinaLogic® bone growth stimulator. The electronic control 
module and the transducer coil are depicted. The module includes a 
signal generator that produces an electrical signal which is transmit-
ted to the treatment transducer. The transducer coil is an elliptically 
shaped copper wire coil that converts the electrical signal into an 
electromagnetic field
Fig. 2  Model of SpinaLogic® 
transducer coil. The x and y 
axes were chosen to coincide 
with the minor and major axes 
of the coil, respectively
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of its availability and the extensive rework that would be 
involved in rescaling it to represent the male lumbar spine. 
Other studies have also used the female spine in their mod-
elling [6]. The model contains the L1 through L5 verte-
brae and their associated intervertebral discs. Dimensions 
for the lumbar vertebrae were obtained from the literature 
[11, 53, 56, 57]. The interbody fusion model was created 
by replacing the tissue within the intervertebral spaces with 
blood as the graft material. The posterolateral fusion model 
was created by reducing the bone on the posterior faces to 
simulate decortication and replacing the tissue with blood 
[50]. The dielectric properties of cortical bone, cancellous 
bone, and soft tissues were specified in terms of conductiv-
ity and permittivity with values obtained from the literature 
[18, 19, 51].
2.3  Electromagnetic field simulation
ElectroMagnetic Simulation (EMS) software was used for 
simulating the magnetic and electric fields (ElectroMag-
neticWorks, Montreal, Quebec, Canada). The software 
was chosen because it is fully embedded in SolidWorks 
(Dassault Systèmes SolidWorks Corp., Waltham, Mas-
sachusetts), the same software that was used to create the 
SpinaLogic® and anatomical spine CAD models. EMS uses 
the finite element method which is also compatible with 
the complexity of the spine model. The transient magnetic 
analysis option was chosen for magnetic field simulations 
in order to model simultaneously both the AC and DC com-
ponents of the magnetic field. The computations for the 
transient analysis were run until steady state was reached.
For low-frequency electromagnetic fields, displace-
ment currents are neglected (magneto-quasistatic analy-
sis), and the electric field is calculated directly from 
the time harmonic form of the Maxwell–Faraday equa-
tion given by ∇ × �E = −jω�B. The AC magnetic analy-
sis option was used because the EF depends only on the 
AC magnetic field. The relative magnetic permeability, 
electrical permittivity, and electrical conductivities for 
cortical bone, cancellous bone, blood, and the surround-
ing medium (air and all other soft tissues) were speci-
fied for the transient and AC magnetic analyses as listed 
in Tables 1 and 2 for the tissues shown in Fig. 3. The 
electrical conductivity is required to compute the cur-
rent density within the coil, whereas only the magnetic 
and electric fields were computed for the spine model. 
To verify the EMS simulations, all fields were also cal-
culated using a magnetic vector potential approach for 
an equivalent elliptical coil [7, 24] and programmed in 
MathCad (PTC, Needham, MA).  
To provide an estimate of the far-field boundary condi-
tions, the tangential and normal components of the MFD, 
B(x, y, z), for the elliptical coil were calculated to determine 
the distances where their magnitudes were less than 0.5 μT. 
Since the curvature of the SpinaLogic® coil along the major 
and minor axes is relatively small, this approximation was 
deemed adequate for the simulations. Moreover, a sensi-
tivity analysis was conducted by varying the location of 
the far-field boundary conditions, checking the difference 
introduced at the calibration point, and finally comparing 
the solution along the z-axis to the magnetic vector poten-
tial solution for the elliptical coil.
Table 1  Material properties for transient analysis
Fig. ID Component Material type Permittivity Relative permeability Electrical conductivity (S/m)
A Vertebrae, inner Cancellous bone 8.0E5 1 0.1
B Vertebrae, outer Cortical bone 3.162E3 1 0.016
C Disc Blood 3.162E3 1 0.66
D Coil Copper 1.0 0.999991 5.7E7
E Surrounding medium, inner/near Air 1.0 1 0.0
F Surrounding medium, outer/far Air 1.0 1 0.0
Table 2  Material properties for AC analysis
Fig. ID Component Material type Permittivity Relative permeability Electrical conductivity (S/m)
A Vertebrae, inner Cancellous bone 8.0E5 1 20
B Vertebrae, outer Cortical bone 3.162E3 1 20
C Disc Blood 8.0E5 1 20
D Coil Copper 1.0 0.999991 5.7E7
E Surrounding medium, inner/near N/A 8.0E5 1 20
F Surrounding medium, outer/far N/A 8.0E5 1 20
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To summarize, a realistic anatomical model was devel-
oped for both interbody and posterolateral fusion proce-
dures. The CMF generated by the SpinaLogic® transducer 
coil was then computationally modelled to assess whether 
the field exceeded the putative therapeutic limit within the 
fusion site. Finally, the EF was computed and compared 
with the open literature to determine whether its amplitude 
exceeded the threshold for a biological response.
3  Results
The SpinaLogic® coil and a realistic anatomical model of 
the lumbar spine were efficiently meshed (Figs. 4a, 5a), 
and simulations of the EMF were generated for both inter-
body and posterolateral fusion procedures. The MFD was 
unchanged by the introduction of the anatomical model 
because the magnetic permeability of these tissues is essen-






∣ for the 
coronal plane at z = 0.1016 m (the calibration plane) and 
the mid-sagittal plane is shown in Figs. 4b and 5b, respec-
tively. The depth of penetration corresponding to the lower 







∣ for the calibration plane and the mid-sagittal 
plane is shown in Figs. 4c and 5c, respectively. The maxi-
mum amplitude of the electric field was 3.6*10−4 V/m in 
the graft tissue within the calibration plane. There are no 
known biological effects at these amplitudes [25].
3.1  Magnetic field simulation for interbody fusion






∣ for the trans-
verse planes intersecting the vertebral column is shown in 
the insets in Fig. 6. For example, for the L1–L2 transverse 
plane, the plane was positioned midway between the infe-
rior endplate of the L1 vertebra and superior endplate of 
the L2 vertebra at the appropriate lordotic angle [11]. The 
Fig. 3  Tissues modelled in anatomical model and surrounding 
medium
Fig. 4  Simulation of the magnetic flux density and electric field for 
the coronal plane at z = 0.1016 m (calibration plane): a anatomi-



















∣ exceeds the lower limit of 






∣ is lower than the threshold for a 
biological effect. In b and c, the coil is 0.10 m in front of the spine
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Fig. 5  Simulation of the magnetic flux density and electric field for 
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∣ is lower than the threshold for a biological effect






∣, for the transverse planes bisecting the intervertebral disc space 







exceeds the lower limit of 22.0 μT for each plane providing 100 % 
coverage of the interbody fusion site. The inferior vertebra is shown 
in a through d
119Med Biol Eng Comput (2016) 54:113–122 
1 3
plane was chosen to bisect the intervertebral disc space 







for this plane provided areal coverage of 100 % (Fig. 6a). 






∣ for the transverse planes 
bisecting L2–L3, L3–L4, L4–L5, and L5–S1 provided areal 
coverages of 100 % for all planes (Fig. 6b–e).
3.2  Magnetic field simulation for posterolateral fusion






∣ for the pos-
terior planes paralleling the vertebral column is shown in 
the insets in Fig. 7. These planes were chosen to span the 
fusion area for each intervertebral space from L1 to L5. 
For example, a posterior plane was positioned to span the 
intervertebral space from L1 to L2 where the graft material 






∣ for this plane surpassed 
the lower limit with minimum and maximum values of 67.5 
and 78.0 μT (Fig. 7a). Similarly, the planes spanning L2–
L3, L3–L4, L4–L5, and L5–S1 surpassed the lower limit 
with minimum values of 60.0, 60.5, 61.5, and 68.5 μT, 
respectively, and maximum values of 67.0, 65.0, 69.5, and 
93.0 μT, respectively (Fig. 7b–e).
4  Discussion
Realistic anatomical models are necessary when determin-
ing the coverage of the bone graft material for lumbar spine 
fusion sites by a medical device using EMF. For this pur-
pose, an anatomical model of the lumbar spine was devel-
oped, and the EMF generated by the SpinaLogic® was sim-
ulated to determine the coverage of the graft material for 
both interbody and posterolateral spinal fusion procedures 
involving the L1–L5 vertebrae. The simulations indicate 
that there is 100 % coverage by the therapeutic magnetic 
field of all spinal fusion sites. To the authors’ knowledge, 
there are no other published studies of extremely low-fre-
quency and extremely low-intensity magnetic field applied 
to spinal fusion procedures.
Critical to the accuracy of the simulations was the selec-
tion of the boundary conditions. The MFD for the far-field 
boundary condition was determined first by numerical 
integration of the Biot–Savart law as applied to an ellipti-
cal coil in air. For the SpinaLogic® simulations, the normal 
and tangential components were set to zero at the distance 
calculated for the elliptical coil, which introduced absolute 






∣, for the postero-
lateral planes spanning the intervertebral disc space between: a L1–






∣ exceeds the lower 
limit of 22.0 μT for each plane providing 100 % coverage of the pos-
terolateral fusion site
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errors of approximately 0.5 μT at the boundaries. At the 
calibration point, this translated to an error of 1.25 % or 
less. This first exercise of the model in air validated its use 
for the more complex simulations of single and multilevel 
fusions.
The introduction of the anatomical model of the spine 
for the L1–L5 vertebrae did not affect the magnitude of the 
MFD. Thus, every point within the fusion volume realized 
the effects of the magnetic field, which is a fundamental 
property of magnetic fields when interacting with nonmag-
netic material. From a biological standpoint, this property 
allows CMF to stimulate all cells and their intracellular com-
ponents within the treatment volume required for bone repair 
or consolidation. Furthermore, since the magnitude includes 
all three components of the magnetic field, the in-specifica-






∣ exceeds specifications based on 







∣ than is currently attributed to the SpinaLogic® 
device. Based on biophysical principles, it can be argued that 
bone cells involved with the repair and consolidation of the 
fusion volume are stimulated by the magnitude, not by a sin-
gle component, of the combined magnetic fields.
The limits for the MFD were critical in determining 
the coverage of the fusion sites. For the lower therapeutic 
limit, clinical data were used to estimate the thickness of 
the soft tissues to the L4–L5 space, which is where most of 
the fusions occurred in the CMF spinal fusion study. The 
assumption is that the MFD at this depth of penetration 
accounted for the successful fusions in the treated popu-
lation. However, the lower limit for a therapeutic effect is 
currently unknown, so this derived limit is speculative at 
best. In lieu of additional clinical research, this approach 
was considered to be better than basing the therapeutic 
field on engineering tolerances. Biological effects have 
been noted for time-varying magnetic fields at 1.0 μT 
[49]. For the upper limit, a higher MFD is presumed to be 
therapeutically beneficial because an increase in intensity 
of this magnitude most likely leads to a higher probability 
of receptor–ligand binding [38]. Further clinical studies are 
needed to determine the full range of magnetic field inten-
sities that are therapeutically beneficial.
For the interbody fusion, the areal sections from the 
simulation demonstrated that the entire fusion volume 
was stimulated by the in-specification magnetic field. The 
area in-specification covered 100 % of the area involved 
in the fusion for the transverse planes associated with the 
intervertebral spaces. Thus, the depth of penetration of the 
magnetic field was sufficient to stimulate the entire bone 
graft volume from the anterior to the posterior surfaces for 
all lumbar vertebrae. Likewise, the areal sections from the 
simulation of the posterolateral fusion demonstrated that 
the entire L1–L5 fusion volume was 100 % covered by the 
magnetic field. The MFD ranged from 60.0 to 93.0 μT for 
all posterior planes. Thus, the height and width of the mag-
netic field were sufficient to stimulate the entire bone graft 
volume for all lumbar vertebrae. The simulation of these 
two very different fusion procedures supports the assertion 
that the coverage by the magnetic field of the SpinaLogic® 
is extremely robust.
The magnitudes of the electric field for the simulations 
of both the anterior interbody and posterolateral fusion 
were below thresholds known to elicit a biological effect 
[25]. This is not surprising because the SpinaLogic® bone 
growth stimulator was designed to provide combined mag-
netic fields at an extremely low frequency of 76.6 Hz and at 
an extremely low intensity of 40.0 μT, peak to peak, with 
a 20.0-μT DC offset. Therefore, the electric field does not 
contribute to the therapeutic effect, and the efficacy of the 
SpinaLogic® must depend on the interaction of cells with 
the CMF (or on some yet unknown exotic physical phenom-
enon). This is somewhat surprising since most EMF-based 
bone growth stimulators are thought to depend on electrical 
stimulation to achieve their effect [40]. However, it should 
be noted that there are currently multiple biophysical mech-
anisms that have been proposed that couple low-intensity 
ELF-MF to molecular/cellular phenomenon [9, 17].
Although the biophysical mechanism is unknown, the 
site of transduction of the magnetic field by an individual 
cell may be conjectured. Gartzke and Lange [20] argue for 
direct energy transfer from ELF-MF to Ca++ at the asso-
ciated ion cyclotron resonance frequency in microvilli 
located on the cell surface. Filamentous actin mediates 
Ca++ signalling within the microvilli by limiting diffusion 
of divalent cations and providing a store for Ca++ [30]. 
Cations are loosely bound to the anionic charge centres 
along F-actin bundles and can flow when exposed to low-
intensity ELF-MF because each cation is acted upon simul-
taneously by the magnetic field. Further experiments using 
CMF to explore Ca++ signalling along F-actin bundles are 
warranted especially ones that manipulate the states of the 
microvilli. However, it should be noted that F-actin itself 
may be effected by ELF-MF. Human mesenchymal cells 
exposed to a nonpulsed, sinusoidal EMF using a high-
amplitude alternating field (1 mT) at 50 Hz induced dras-
tic changes in cell morphology as evidenced by increased 
actin formation and redistribution [31].
The time course of insulin-like growth factors and their 
related binding proteins (IGFs and IGFBPs) was recently 
investigated in a nonunion model in the rat [29]. The model 
was created by cauterizing the periosteum after fracture and 
is expected to successfully reproduce a nonunion. IGF-II 
was significantly upregulated in nonunions compared with 
normal healing fractures at 7 days postfracture. In addition, 
IGFBP-6 was upregulated at 7, 14, and 28 days postfracture 
and also plays a major role in inhibiting osteoblast differen-
tiation [22]. Ryaby et al. [45] assumed that stimulation of 
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IGF-II by CMF promoted the healing of nonunions and spi-
nal fusions in clinical trials. However, IGF-II was also down-
regulated at day 14 postfracture in the same study. Thus, 
the therapeutic effect of CMF may be to modulate IGF-II 
directly or to downregulate IGFB-6 at the appropriate time 
points. Using the same nonunion and normal fracture healing 
models, experiments could be conducted to elucidate the role 
of CMF in modulating IGF-II and its binding proteins.
5  Conclusions
Based on the modelling completed for this study, the CMF 
generated by the SpinaLogic® provides targeted and com-
plete coverage for both interbody and posterolateral spi-
nal fusion procedures involving the L1–L5 vertebrae. The 
SpinaLogic® bone growth stimulator utilizes CMF that can 
be characterized as extremely low-frequency and extremely 
low-intensity magnetic fields. The amplitude of the associ-
ated electric field is less than the thresholds for a biological 
effect [25]. However, clinical experience supports the effi-
cacy of the SpinaLogic® stimulator when compared with 
other bone growth stimulators that employ electromagnetic 
fields. Therefore, CMF must interact with bone graft mate-
rial via magnetic fields to promote repair and consolida-
tion of the fusion volume. Moreover, the coverage by the 
SpinaLogic® is more than adequate to stimulate multi-level 
spinal fusions. Indeed, simulations of the magnetic field for 
both interbody and posterolateral fusions show that 100 % 
of the fusion volumes are stimulated.
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